Morgan Stanley Lowers Lam Research Price Target to $339
- Rating
- Buy
- Target
- $339
- from $385 (−12%)
- Upside
- +46%
- LRCX at $233 today

What the analyst said
Morgan Stanley analyst Shane Brett lowered the price target on Lam Research (NASDAQ: LRCX) to $339 (from $385) while maintaining an Overweight rating.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
LRCX trades at $233. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $339 target is 3% below the median.
12-month window: day 1 of 365, closes on October 22, 2027.
Track record
This callOpen: LRCX has not reached $339 yet. This 12-month target is scored on October 22, 2027.
Firm track recordMorgan Stanley: 89% of its 27 targets at least a year old were reached within 12 months (#7 of 28 firms). Accuracy ranking →
Morgan Stanley on Lam Research
Morgan Stanley price targets on Lam Research
8 calls from January 29, 2026 to October 22, 2026. The target went from $244 to $339 (+39%). The rating stayed Buy.
- October 22, 2026 This noteTarget cut from $367 (−8%)Buy$339
- July 30, 2026Target cut from $404 (−9%)Buy$367
- July 6, 2026Target raised from $331 (+22%)Buy$404
- May 18, 2026Target raised from $293 (+13%)Buy$331
- April 23, 2026Target raised from $260 (+13%)$293
- April 6, 2026Target raised from $254 (+2%)$260
- February 25, 2026Target raised from $244 (+4%)$254
- January 29, 2026Earliest call shown$244




